April 10, 2021
Business News

Caribou Biosciences to Participate in Three Upcoming Investor Conferences in March

BERKELEY, Calif.–()–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today that Rachel Haurwitz, Ph.D., Caribou’s President and Chief Executive Officer, will present a company overview at upcoming investor conferences in March.

  • Barclays Global Healthcare Conference on Tuesday, March 9, 2021 at 1:15 p.m. ET
  • Spring Private Company Showcase hosted by Solebury Trout, Credit Suisse, and Cooley on Thursday, March 11, 2021 at 11:40 a.m. ET

A live and archived webcast of the presentations will be accessible via Caribou’s website at https://cariboubio.com/news/events for 30 days following the events.

Additionally, the company will participate in meetings…

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
China fines Alibaba record $2.75 billion for anti-monopoly violations – Reuters
Article feature image
Hawaii governor lays foundation for vaccinated travelers to avoid quarantine – The Points Guy
Article feature image
AstraZeneca Vaccine and Blood Clots: What Is Known So Far – The New York Times